Citations

Showing 10 of 108094 citations.

Congenital Restrictive Strabismus
Bata, Bashar M. , Garrity, James A., Brodsky, Michael C.

Mayo Clinic

JAMA Ophthalmology | January 18, 2018 | Volume: 136 | Issue: 4 | Pages: 442

10.1001/jamaophthalmol.2017.4345 | PMID 29346468 Get It

Percutaneous access to the heart: Nontraditional approaches for the electrophysiologist
Asirvatham, Samuel J. , Asirvatham, Samuel J

Mayo Clinic

Journal of Cardiovascular Electrophysiology | January 18, 2018 | Volume: 29 | Issue: 3 | Pages: 504-505

10.1111/jce.13427 | PMID 29345389 Get It

Faculty Opinions recommendation of Therapies targeting DNA and RNA in Huntington's disease.
Caviness, John N.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 18, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.731220229.793541473 Get It

Refractory Pulmonary Edema and Upper Body Hypoxemia During Veno‐Arterial Extracorporeal Membrane Oxygenation—A Case for Atrial Septostomy
Prasad, Amit , Ghodsizad, Ali , Kozak, Mark, Körner, Michael, Banayosy, Aly El, Singbartl, Kai , Singbartl, Kai , Brehm, Christoph E

Mayo Clinic

Artificial Organs | January 18, 2018 | Volume: 42 | Issue: 6 | Pages: 664-669

10.1111/aor.13082 | PMID 29344963 Get It

AbstractVeno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) provides mechanical circulatory support for patients with advanced cardiogenic shock, facilitating myocardial recovery and limiting multi‐organ failure. In patients with severely limited left ventricular ejection, peripheral VA‐ECMO can further increase left ventricular and left atrial pressures (LAP). Failure to decompress the left heart under these circumstances can result in pulmonary edema and upper body hypoxemia, that is, myocardial and cerebral ischemia. Atrial septostomy can decrease LAP in these situations. However, the effects of atrial septostomy on upper body oxygenation remain unknown. After IRB approval, we identified 9 out of 242 adult VA‐ECMO patients between January 2011 and June 2016 who also underwent atrial septostomy for refractory pulmonary edema/upper body hypoxemia. We analyzed LAP/pulmonary capillary wedge pressure (PCWP), right atrial pressures (RAPs), PaO2/FiO2 ratios (blood samples from right radial artery), intrathoracic volume status, and resolution of pulmonary edema before and up to 48 h after septostomy. There were no procedure‐related complications. Thirty‐day survival was 44%. LAP/PCWP decreased by approximately 40% immediately following septostomy and remained so for at least 24 h. PaO2/FiO2 ratios significantly increased from 0.49 (0.38–2.12) before to 5.35 (3.01–7.69) immediately after septostomy and continued so for 24 h, 6.6 (4.49–10.93). Radiographic measurements also indicated a significant improvement in thoracic intravascular volume status after atrial septostomy. Atrial septostomy reduces LAP and improves upper body oxygenation and intrathoracic vascular volume status in patients developing severe refractory pulmonary edema while undergoing peripheral VA‐ECMO. Atrial septostomy therefore appears safe and suitable to reduce the risk of upper body ischemia under these circumstances.
Assessing the underlying pattern of human germline mutations: lessons from the factor IX gene
Sommer, Steve S.

Mayo Clinic

The FASEB Journal | January 18, 2018 | Volume: 6 | Issue: 10 | Pages: 2767-2774

10.1096/fasebj.6.10.1634040 | PMID 1634040 Get It

Germline mutations cause or predispose to most diseases. Hemophilia B is a useful model for studying the underlying pattern of recent germline mutations in humans because the observed pattern of mutation in factor IX more closely reflects the underlying pattern of mutation than the observed pattern for many other genes. In addition, it is possible to identify and correct for biases inherent in ascertaining only those mutations that cause hemophilia. Aspects of the pattern of germline mutation in the factor IX gene are becoming clear: 1 ) in the United States, two‐thirds of mutations causing mild disease arose from three founders whereas almost all the mutations resulting in either moderate or severe disease arose independently, generally within the past 150 years; 2 ) direct estimates of the rates of mutation in humans indicate that transitions are more frequent than transversions, which in turn are more frequent than deletions and insertions; 3 ) transitions at CpG are elevated approximately 24‐fold relative to transitions at non‐CpG dinucleotides; 4 ) transversions at CpG are elevated approximately eightfold relative to transversions at non‐CpG dinucleotides; 5 ) the sum total of the dinucleotide mutation rates produces a bias against G and C bases that would be sufficient to maintain the G+C content of the factor IX gene at its evolutionarily conserved level of 40%; and 6 ) the pattern of mutation is similar for Caucasians residing in the United States and for Asians residing in Asia. Two ideas emerge from this and from an analysis of the pattern of recent deleterious mutations compared with ancient neutral mutations that have been fixed during evolution into the factor IX gene. First, the bulk of germline mutations are likely to arise from endogenous processes rather than environmental mutagens. Second, the factor IX protein is composed mostly of two classes of amino acids: critical residues in which all single‐base missense changes will disrupt protein function, and “spacer” residues in which the precise nature of the residue is unimportant but the peptide bond is necessary to keep the critical residues in register. More work is necessary to assess the veracity and generality of these ideas.— Sommer, S. S. Assessing the underlying pattern of human germline mutations: lessons from the factor IX gene. FASEB J. 6: 2767‐2774; 1992.
A role for bone turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma
Vallet, Sonia , Hoyle, Nicholas R, Kyle, Robert A. , Podar, Klaus , Pecherstorfer, Martin

Mayo Clinic

Leukemia & Lymphoma | January 18, 2018 | Volume: 59 | Issue: 10 | Pages: 2431-2438

10.1080/10428194.2017.1421757 | PMID 29345175 Get It

Endothelium‐derived relaxing and contracting factors
Furchgott, Robert F., Vanhoutte, Paul M.

Mayo Clinic

The FASEB Journal | January 18, 2018 | Volume: 3 | Issue: 9 | Pages: 2007-2018

10.1096/fasebj.3.9.2545495 Get It

Endothelium‐dependent relaxation of blood vessels is produced by a large number of agents (e.g., acetylcholine, ATP and ADP, substance P, bradykinin, histamine, thrombin, serotonin). With some agents, relaxation may be limited to certain species and/or blood vessels. Relaxation results from release of a very labile non‐prostanoid endothelium‐derived relaxing factor (EDRF) or factors. EDRF stimulates guanylate cyclase of the vascular smooth muscle, with the resulting increase in cyclic GMP activating relaxation. EDRF is rapidly inactivated by hemoglobin and superoxide. There is strong evidence that EDRF from many blood vessels and from cultured endothelial cells is nitric oxide (NO) and that its precursor is L‐arginine. There is evidence for other relaxing factors, including an endothelium‐derived hyperpolarizing factor in some vessels. Flow‐induced shear stress also stimulates EDRF release. Endothelium‐dependent relaxation occurs in resistance vessels as well as in larger arteries, and is generally more pronounced in arteries than veins. EDRF also inhibits platelet aggregation and adhesion to the blood vessel wall. Endothelium‐derived contracting factors appear to be responsible for endothelium‐dependent contractions produced by arachidonic acid and hypoxia in isolated systemic vessels and by certain agents and by rapid stretch in isolated cerebral vessels. In all such experiments, the endothelium‐derived contracting factor appears to be some product or by‐product of cyclooxygenase activity. Recently, endothelial cells in culture have been found to synthesize a peptide, endothelin, which is an extremely potent vasoconstrictor. The possible physiological roles and pathophysiological significance of endothelium‐derived relaxing and contracting factors are briefly discussed.— F urchgott , R. F.; V anhoutte , P. M. Endothelium‐derived relaxing and contracting factors. FASEB J. 3: 2007‐2018; 1989.
The role of proteases during apoptosis
Patel, Tushar , Gores, Gregory J. , Kaufmann, Scott H.

Mayo Clinic

The FASEB Journal | January 18, 2018 | Volume: 10 | Issue: 5 | Pages: 587-597

10.1096/fasebj.10.5.8621058 | PMID 8621058 Get It

The importance of proteases during apoptosis is becoming increasingly apparent. Because apoptosis contributes to a diverse variety of disease processes, understanding the roles played by proteases and their inhibitors might provide insight into the pathogenesis of these conditions and suggest novel therapeutic strategies. In this review, we discuss the involvement and role of specific proteases, substrates, and protease inhibitors that appear to participate in the apoptotic process.—Patel, T., Gores, G. J., Kaufmann, S. H. The role of proteases during apoptosis. FASEB J. 10, 587‐597 (1996)
Sulfotransferase molecular biology: cDNAs and genes
Weinshilboum, Richard M. , Otterness, Diane M., Aksoy, Ibrahim A., Wood, Thomas C., Her, Chengtao, Raftogianis, Rebecca B., Weinshilboum, Richard M.

Mayo Clinic

The FASEB Journal | January 18, 2018 | Volume: 11 | Issue: 1 | Pages: 3-14

10.1096/fasebj.11.1.9034160 Get It

Sulfotransferase (ST) enzymes cata‐lyze the sulfate conjugation of many hormones, neu‐rotransmitters, drugs, and xenobiotic compounds. These reactions result in enhanced renal excretion of the sulfate‐conjugated reaction products, but they can also lead to the formation of “bioactivated” metabolites. ST enzymes are members of an emerging gene superfamily that presently includes phenol ST (PST), hydroxysteroid ST (HSST), and, in plants, flavonol ST (FST) “families,” members of which share at least 45% amino acid sequence iden‐tity. These families can be further subdivided into “subfamilies” that are at least 60% identical in amino acid sequence. For example, the PST family includes both PST and estrogen ST (EST) subfamilies. Amino acid sequence motifs exist within ST enzymes that are conserved throughout phylogeny. These signature sequences may be involved in the binding of 3 ‘‐phosphoadenosine‐5 ‘‐phosphosulfate, the cosubstrate for the sulfonation reaction. There are presently five known human cytosolic ST en‐zymes: an EST, an HSST, and three PSTs. cDNAs and genes for all of these enzymes have been cloned, and chromosomal localizations have been reported for all five genes. Genes for these human enzymes, as well as those of other mammalian cytosolic ST enzymes that have been cloned, show a high degree of structural homology, with conservation of the lo‐cations of most intron/exon splice junctions. Human ST enzyme expression varies among individuals. Functionally significant genetic polymorphisms for ST enzymes in humans have been reported, and other molecular genetic mechanisms that might be involved in the regulation of the expression of these enzymes are being explored. Knowledge of the mo‐lecular biology of cytosolic ST enzymes, when placed within a context provided by decades of biochemical research, promises to significantly enhance our understanding of the regulation of the sulfate conjugation of hormones, neurotransmitters, and drugs.—Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., Rafto‐ gianis, R. B. Sulfotransferase molecular biology: cDNAs and genes. FASEB J. 11, 3‐14 (1997)
The Effect of Diuresis on Extravascular Lung Water and Pulmonary Function in Acute Decompensated Heart Failure
Chase, Steven C. , Fermoyle, Caitlin C. , Wheatley, Courtney M. , Schaefer, Jacob J. , Olson, Lyle J. , Johnson, Bruce D.

Mayo Clinic

ESC Heart Failure | January 18, 2018 | Volume: 5 | Issue: 2 | Pages: 364-371

10.1002/ehf2.12253 | PMID 29345431 Get It

Abstract Aims The effect of extravascular lung water (EVLW) and relationship to functional status as a result of acute decompensated heart failure (ADHF) are not well understood. We sought to quantify changes in clinical variables, EVLW, airway anatomy, spirometry, and diffusing capacity for carbon monoxide before and after treatment for ADHF. Methods and results Fifteen patients were recruited within 24 h of hospital admission. Spirometry, diffusing capacity for carbon monoxide, and surrogates of EVLW by computed tomography were measured and were then repeated within 24 h of discharge. From the computed tomography (CT) scan, surrogates of EVLW were calculated from the distribution of CT attenuation of the lung tissue. Airways were segmented using the Vida Apollo software. Patients were hospitalized for 4.6 ± 2.1 days, had 10 ± 4.8 L of fluid removed (7.0 ± 4.2 L between study visits), and lost 7.1 ± 4.9 kg. Patients had significant clearance of fluid from the lungs (per cent change: mean, 4.2 ± 6.1%; skew, 17.5 ± 27.0%; kurtosis, 37.6 ± 56.7%; full-width half-maximum, 10.2 ± 13.5%). Static lung volumes and maximal flows improved significantly (per cent change: forced vital capacity, 14.5 ± 13.6%; forced expiratory volume in 1 s, 15.9 ± 14.0%; forced expiratory flow at 25–75% of forced vital capacity, 27.2 ± 42.9%). The ratio of membrane conductance to capillary blood volume improved significantly (per cent change: alveolar–capillary membrane conductance/capillary blood volume, 23.4 ± 22.8%). Weight loss during hospitalization was significantly correlated with improved spirometry and diffusing capacity. Conclusions Extravascular lung water contributes to the pulmonary congestive syndrome in ADHF patients, and its clearance is an important component of the improvement in pulmonary function as a result of inpatient treatment.